Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> DMS Pharmaceutical loses its challenge to the VA
FDAnews Drug Daily Bulletin
April 10, 2012
| Vol. 9 No. 71
DMS Pharmaceutical loses its challenge to the VA
DMS Pharmaceutical Group lost a challenge to a decision by the United States Department of Veterans Affairs to exclude small businesses from a drug supply contract valued at as much as $32 billion.
China Daily
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Full Issue
Correction
Astellas Scraps EU Marketing Plans for Kidney Cancer Candidate
Merck Ends Trials For Once-Promising Parkinson’s Drug